Liver cirrhosis is a process of destruction and regeneration of the liver. As a result, severe fibrosis (scarring) occurs, and eventually, the liver deteriorates and ceases to function properly. Without treatment, it can lead to liver cancer. It is estimated that this disease affects 185 million people worldwide—equivalent to 2.4% of the total global population—and causes 1 million deaths per year.
Regarding the causes of liver cirrhosis, the most common is hepatitis B (40%), followed by alcohol-related hepatitis (20–25%) and hepatitis C (20%, although this rate is declining rapidly due to new treatments); followed by fatty liver disease (10–15%), which is on the rise, and, accounting for 1% to 3% of cases, Wilson’s disease, autoimmune hepatitis, and primary biliary cholangitis. The diagnosis of liver cirrhosis is made based on laboratory test results and imaging techniques such as MRI, CT scan, or ultrasound. A liver biopsy is often necessary to determine the cause of liver cirrhosis, as treatment may vary depending on the etiology. However, a biopsy sometimes cannot be performed due to coagulation déficits that could lead to hemorrhage.
The role of immunoglobulins in the diagnosis of liver cirrhosis
A study published in the European Journal of Gastroenterology and Hepatology included 319 patients diagnosed with liver cirrhosis: 60 of them with autoimmune liver disease (AIH), 86 with primary biliary cholangitis (PBC), 48 with alcoholic liver disease, and 41 with fatty liver disease. Quantitative measurements of IgG, IgA, and IgM immunoglobulins were performed to attempt to differentiate the various causes of cirrhosis without a liver biopsy. Patients with AIH had the highest levels of IgG. In contrast, patients with AIH showed lower IgM levels compared to those with PBC and lower IgA levels compared to those with alcoholic liver disease. Regarding IgG quantification, it was found that patients with AIH had IgG levels above 2000 mg/dl compared to the others. This threshold demonstrated a diagnostic sensitivity of 82% and a specificity of 74%.
In summary, immunoglobulin levels can be useful in the differential diagnosis of liver cirrhosis. Both Dr. Carreño and the doctors at the foundation take these results into account when treating our patients.


